Evidence map›Paper›PMID 37226847›Full record

ArticleGut2024

Antibiotic use and inflammatory bowel disease: number needed to harm? Authors' reply.

Adam S Faye, Tine Jess

Abstract readLetterComment
In one paragraph

Article in Gut, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Adam S FayeDepartment of Medicine and Population Health, New York University Grossman School of Medicine, New York, New York, USA adam.faye@nyulangone.org.ORCID 0000-0002-1571-5856
Tine JessCenter for Molecular Prediction of Inflammatory Bowel Disease, Department of Clinical Medicine, Aalborg Universitet, Copenhagen, Denmark.ORCID 0000-0002-4391-7332

Funding

Sarcopenia as a Preoperative Risk Stratification Tool Among Older Adults with Inflammatory Bowel DiseaseR03AG078927 · NIA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI FAYE, ADAM SCOTTE · 2022 to 2023
$339k
NIA NIH HHS R03 AG078927
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Colitis, UlcerativeInflammatory Bowel DiseasesAnti-Bacterial AgentsHumansAnti-Bacterial AgentsANTIBIOTICSCROHN'S DISEASEIBDULCERATIVE COLITIS

Identifiers

PMID37226847
PMCPMC10522786

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.